The companies are looking to get Relistor approved for the treatment of opioid-induced constipation (:OIC) in patients taking opioids for chronic non-cancer pain. Relistor is a peripherally acting ...
Marketing Approval Expands Treatment to Include Nearly 11 Million Patients Who Experience Opioid-Induced Constipation While Taking Opioids for Chronic Non-Cancer Pain RALEIGH, N.C. & TARRYTOWN, N.Y.-- ...
With oral Relistor's approval, Valeant just got a new weapon in its battle with AstraZeneca for the opioid-induced constipation throne. Can that weapon reach the billion-dollar sales benchmark quoted ...
Data from a Post-Hoc Analysis Supports the Use of Salix's RELISTOR for Patients with Opioid-Induced Constipation and Advanced Illness in the Emergency Department Setting LAVAL, QC, Dec. 22, 2021 ...
The approval of Relistor (a subcutaneous injection for the treatment of opioid induced constipation in patients with chronic non-cancer pain) by the FDA last week, triggered a $40 million milestone ...
Relistor is a drug that people use to treat constipation that opioid medications can cause. Relistor is effective because it does so without reducing the pain-relieving effects of the opioid drugs.
LAVAL, Quebec and TARRYTOWN, N.Y., April 24, 2015 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that ...
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...
Salix Pharmaceuticals (NASDAQ:SLXP) is a step closer to bringing to the U.S. Food and Drug Administration a once-a-day pill version of injectable constipation drug Relistor. Discover the top ...
Salix, which specializes in gastrointestinal treatments, could pay Progenics another $90 million if the company reaches certain regulatory milestones in the United States. Salix will fund development, ...
NEW YORK, Oct 14 (Reuters) - Progenics Pharmaceuticals Inc said on Wednesday it reached a deal with Wyeth to regain worldwide rights to Relistor, a medicine used to treat constipation caused by opioid ...
BRIDGEWATER, N.J., June 3, 2021 /PRNewswire/ -- Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results